Found: 57
Select item for more details and to access through your institution.
The role of microbiome in pancreatic cancer.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 777, doi. 10.1007/s10555-021-09982-2
- By:
- Publication type:
- Article
Treatment options for HER2-expressing colorectal cancer: updates and recent approvals.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231225037
- By:
- Publication type:
- Article
ASO Visual Abstract: Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis—Results from a Prospective Pilot Study.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 395, doi. 10.1245/s10434-022-12328-z
- By:
- Publication type:
- Article
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1037, doi. 10.1007/s10637-018-0600-2
- By:
- Publication type:
- Article
Sister Mary Joseph Nodule in Advanced Pancreatic Adenocarcinoma Identified on <sup>18</sup>F-FDG PET/MRI.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Abstracts From the 18th Annual Meeting of the International Society of Gastrointestinal Oncology.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 11, p. 752, doi. 10.46883/onc.2021.3511.0752
- By:
- Publication type:
- Article
Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer... [including commentary by Takayuki Yoshino}.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 10, p. 654
- By:
- Publication type:
- Article
The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 553, doi. 10.46883/onc.2021.3509.0553
- By:
- Publication type:
- Article
Serial Circulating Free DNA Testing Can Detect New Genetic Alterations in Patients Undergoing Treatment for Pancreas Cancer... [including commentary by Daniel G. Haller].
- Published in:
- Oncology (08909091), 2020, v. 34, n. 11, p. 476
- By:
- Publication type:
- Article
Ushering in the Era of Precision Medicine.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 8, p. 314, doi. 10.46883/onc.3408.314
- By:
- Publication type:
- Article
Acquired Immunotherapy Resistance in Gastrointestinal Cancers.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5173, doi. 10.3390/cancers14215173
- By:
- Publication type:
- Article
Multi-Omics Data Analysis of Gene Expressions and Alterations, Cancer-Associated Fibroblast and Immune Infiltrations, Reveals the Onco-Immune Prognostic Relevance of STAT3/CDK2/4/6 in Human Malignancies.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 954, doi. 10.3390/cancers13050954
- By:
- Publication type:
- Article
How Best to Extend Overall Survival in Metastatic Colorectal Cancer: Q&A.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, p. 16
- By:
- Publication type:
- Article
Real-World Data on Sequencing Third-Line Therapies for Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, p. 10
- By:
- Publication type:
- Article
Improving Survival in Metastatic Colorectal Cancer Through Optimized Patient Selection.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, p. 1
- By:
- Publication type:
- Article
Addition of Atezolizumab to FOLFOXIRI/Bevacizumab Prolongs PFS in mCRC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 356
- By:
- Publication type:
- Article
Both Tissue- and Blood-Based Assays Can Be Used to Identify Patients With HER2+ mCRC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 357
- By:
- Publication type:
- Article
Lower Dose of Trastuzumab Deruxtecan Improves Benefit-Risk Profile in HER2+ mCRC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 355
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy Allows Most Patients With Locally Advanced Rectal Cancer to Skip Pelvic Chemoradiation.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 355
- By:
- Publication type:
- Article
Who Is a Candidate for Nonoperative Management of Early-Stage Rectal Cancer?
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 5, p. 281
- By:
- Publication type:
- Article
How Quality of Life Can Inform Management Decisions in Later-Line Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 1
- By:
- Publication type:
- Article
Highlights in Colorectal Cancer From the 2021 American Society of Clinical Oncology Annual Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 11
- By:
- Publication type:
- Article
Regorafenib as Second-Line Therapy After FOLFOXIRI Plus Bevacizumab in a Patient With a KRAS Mutation.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 2
- By:
- Publication type:
- Article
Transitioning From Second-Line to Third-Line Therapy in Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 1
- By:
- Publication type:
- Article
Proactive Transitioning to Third-Line Treatment in Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 5
- By:
- Publication type:
- Article
Cases in the Management of Metastatic Colorectal Cancer: Sequencing Therapies in a Patient With the BRAF V600E Mutation.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 1
- By:
- Publication type:
- Article
Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer: Discussion.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 21
- By:
- Publication type:
- Article
Identifying Disease Progression in Patients With Metastatic Colorectal Cancer: When to Initiate Third-Line Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 2
- By:
- Publication type:
- Article
Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer: Discussion.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 21
- By:
- Publication type:
- Article
Identifying Disease Progression in Patients With Metastatic Colorectal Cancer: When to Initiate Third-Line Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 2
- By:
- Publication type:
- Article
Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, p. 21
- By:
- Publication type:
- Article
Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.794009
- By:
- Publication type:
- Article
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.641044
- By:
- Publication type:
- Article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00076
- By:
- Publication type:
- Article
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 7, p. 726, doi. 10.1002/pds.3633
- By:
- Publication type:
- Article
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer.
- Published in:
- Cancer (0008543X), 2018, v. 124, n. 15, p. 3118, doi. 10.1002/cncr.31552
- By:
- Publication type:
- Article
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 24, p. 4223, doi. 10.1002/cncr.28358
- By:
- Publication type:
- Article
A Single-Institute Experience with Sorafenib in Untreated and Previously Treated Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2010, v. 78, n. 3/4, p. 210, doi. 10.1159/000313701
- By:
- Publication type:
- Article
Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine: A Single-Institute Study.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 333, doi. 10.1159/000209962
- By:
- Publication type:
- Article
Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
- Published in:
- Advanced Biology, 2023, v. 7, n. 4, p. 1, doi. 10.1002/adbi.202101319
- By:
- Publication type:
- Article
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1224, doi. 10.1093/oncolo/oyae098
- By:
- Publication type:
- Article
Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 885, doi. 10.1093/oncolo/oyad200
- By:
- Publication type:
- Article
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. 874, doi. 10.1093/oncolo/oyac150
- By:
- Publication type:
- Article
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. 874, doi. 10.1093/oncolo/oyac150
- By:
- Publication type:
- Article